|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (3Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
David A. Witkin's Beryl Capital Management is an investment manager focused on merger arbitrage. The firm was created back in 2013, and its offices are located in Redondo Beach, California. Since its inception, it has provided services to individual clients, small businesses and pooled investment vehicles mainly across the United States. David Alexander Witkin is […]
Reuters reported on Thursday that Acadia Healthcare Co Inc., an operator of mental-health and addiction-treatment centers, is in buyout talks with firms including KKR & Co. and TPG Global. It also attracted short-seller attention, as Congress pursues legislation that could cut down on the sort of surprise out-of-network bills that Envision is accused of sending.
Envision Healthcare's sale to private investment firm KKR for $9.9 billion has been completed and the company is no longer on the NYSE.
Envision Healthcare Corporation (“Envision” or the “Company”) (EVHC) today announced the completion of the previously announced acquisition of Envision by global investment firm KKR. As a result of the completion of the merger, Envision has become a wholly owned subsidiary of funds affiliated with KKR, and Envision stockholders will receive an amount in cash equal to $46.00 per share of Envision common stock. At June 30, 2018, we delivered physician services, primarily in the areas of emergency department and hospitalist services, anesthesiology services, radiology/tele-radiology services, and children’s services to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia.
NEW YORK , Oct. 4, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Fortinet Inc. (NASD: FTNT) ...
Let's see if Envision Healthcare Corporation (EVHC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
UnitedHealth Group Inc will treat emergency room and other hospital services performed by Envision Healthcare as out-of-network claims beginning next year after failing to reach a new contract agreement with the staffing company, UnitedHealth said on Monday. The letter comes 90 days ahead of the Jan. 1 date for the out-of-network switch, and after months of negotiations between the two companies to solve disagreements over payment rates and other financial incentives, UnitedHealth spokesman Stephen Shivinsky said. UnitedHealth first said it was considering terminating its contract with Envision in April.
UnitedHealthcare says its negotiations with the Envision network of ER doctors has reached an impasse. The insurer sent a letter to hospitals Friday warning that it may drop the doctors group from its plans. UnitedHealthcare's negotiations with the nation's largest provider of emergency room doctors has reached an impasse.
Moody's Investors Service ("Moody's") assigned a Caa1 rating to the new unsecured notes of Enterprise Merger Sub Inc. ("Enterprise"). Enterprise will immediately become Envision Healthcare Corporation ("Envision") once a pending LBO transaction is completed. Proceeds from this debt issuance will be used in conjunction with new equity, senior secured first lien debt, and privately placed unsecured notes (not rated) to fund the LBO of Envision Healthcare Corporation by private equity firm Kohlberg Kravis Roberts & Co. ("KKR").
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The $5.05 billion (3.81 billion pounds) term loan for Envision Healthcare is the third massive leveraged loan to hit the market since September and also looks set to benefit from huge institutional demand which has already seen multibillion buyout loans for Thomson Reuters’ F&R business, Refinitiv, and Akzo Nobel’s Specialty Chemicals business successfully placed. Envision’s loan will bring the total of jumbo loans syndicated since early September to US$20.7bn, in addition to the US$9.25bn loan for Refinitiv and Akzo Nobel’s US$6.44bn loan. Although the commitment deadline for Envision’s loan is October 1, the deal is already fully subscribed and is expected to tighten in line with the two previous jumbo deals, bankers said.